Skip to main content
OpenTrials
Completed

NCT Number: NCT06343623

Superiorly Based Pharyngeal Flap Versus Myomucosal Resection and Direct Closure

Patients were classified into two groups. Group (A) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected by the superiorly based pharyngeal flap. Group (B) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected with myomucosal resection and direct closure of the posterior pharyngeal wall

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Velopharyngeal Insufficiency Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Mouth Abnormalities Mouth Diseases Otorhinolaryngologic Diseases Pharyngeal Diseases Stomatognathic Diseases Stomatognathic System Abnormalities

Age range

4 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of medicine

Minya, 61511, Egypt

About this study

Patients were classified into two groups. Group (A) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected by the superiorly based pharyngeal flap. Group (B) patients included fifty patients had velopharyngeal insufficiency and were surgically corrected with myomucosal resection and direct closure of the posterior pharyngeal wall

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Patients have velopharyngeal insufficiency.
  • Age range 4-10 years

Exclusion criteria

  • - Syndromic patients.

Treatment and study plan

myomucosal resection and direct closure

Procedure

myomucosal resection and direct closure

superiorly based flap

Procedure

superiorly based pharyngeal flap

Primary outcomes

  1. Improvement in the speech outcome

    Time frame: 4 years

    Improvement in the speech outcome using auditory perception assessment and videonasoendoscopy

Secondary outcomes

  1. obstructive sleep apnea

    Time frame: 3 years

    obstructive sleep apnea using respiratory function test

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Apr 2, 2024
Registry last updated
Apr 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.